Abstract
Idiopathic granulomatous mastitis is characterized by non-caseating granuloma and microabscess formation limited to mammary gland lobules. It is a form of chronic mastitis of unknown pathogenesis. In this study, the effectiveness of intralesional steroid injection with topical steroids is compared to systemic steroid therapy in the treatment of idiopathic granulomatous mastitis. Between June 2017 and December 2020, patients were collected and assessed. Idiopathic granulomatous mastitis was diagnosed histopathologically by tru-cut biopsy in patients with breast mass, pain, and erythema with suspicion of idiopathic granulomatous mastitis. Included in the study were one hundred and eleven patients who were diagnosed with idiopathic granulomatous mastitis and were treated with local or oral administration of corticosteroids, with at least 6 months of follow-up. The patients were divided into 2 groups: a local corticosteroid–treatment group (n = 57) and a peroral corticosteroid–treatment group (n = 54). Demographic characteristics, treatment responses, recurrence rates, side effects of the steroid, and the need for surgery were compared. The rate of smoking was 12.3% in the local corticosteroid–treatment group and 20.4% in the peroral corticosteroid–treatment group. There was no history of oral contraceptive use in either group. Previous steroid use was significantly lower in the local corticosteroid–treatment group (10.5%) compared to the peroral corticosteroid–treatment group (55.6%) (p = 0.001). Previous antibiotic use was significantly lower in the local corticosteroid–treatment group (75.4%) compared to the peroral corticosteroid–treatment group (100%) (p = 0.001). Those who responded after the first course of treatment were 96.5% in the local corticosteroid–treatment group versus 75.9% in the peroral corticosteroid–treatment group (p = 0.001). Complete responders after the third course of treatment was 98.2% in the local corticosteroid–treatment group versus 87.0% in the peroral corticosteroid–treatment group (p = 0.003). Recurrence had been 7% of the patients in the local corticosteroid–treatment group compared to 37% in the peroral corticosteroid–treatment group (p = 0.001). Steroid-related side effects were lower in the local corticosteroid–treatment group (0 compared to the peroral corticosteroid–treatment group (11.1%) (p = 0.010). Surgery was performed in 3.5% of the local corticosteroid–treatment group and in 57.3% of the peroral corticosteroid–treatment group (p = 0.001). A comparative open-label study in idiopathic granulamatous mastitis between local infiltration of corticosteroid compared to oral methyl prednisilone both used as single modality therapy has shown better and sustained response to local infiltration of corticosteroids.
Similar content being viewed by others
References
Kessler E, Wolloch Y (1972) Granulomatous mastitis: a lesion clinically simulating carcinoma. Am J Clin Pathol 58(6):642–646. https://doi.org/10.1093/ajcp/58.6.642
Yin Y, Liu X, Meng Q, Han X, Zhang H, Lv Y (2021) Idiopathic granulomatous mastitis: etiology, clinical manifestation, diagnosis and treatment. J Invest Surg 10:1–12. https://doi.org/10.1080/08941939.2021.1894516
Toktas O, Konca C, Trabulus DC, Soyder A, Koksal H, Karanlik H, Kamali Polat A, Ozbas S, Yormaz S, Isik A, Sezgin E, Soran A (2021) A novel first-line treatment alternative for noncomplicated idiopathic granulomatous mastitis: combined intralesional steroid injection with topical steroid administration. Breast Care (Basel) 16(2):181–187. https://doi.org/10.1159/000507951
Haitz K, Ly A, Smith G (2019) Idiopathic granulomatous mastitis. Cutis 103(1):38–42
Baslaim M, Khayat H, Al-Amoudi S (2007) Idiopathic granulomatous mastitis: a heterogeneous disease with variable clinical presentation. World J Surg 31(8):1677–1681. https://doi.org/10.1007/s00268-007-9116-1
Ma X, Min X, Yao C (2020) Different treatments for granulomatous lobular mastitis: a systematic review and meta-analysis. Breast Care (Basel) 15(1):60–66. https://doi.org/10.1159/000501498
Kaviani A, Noveiry B, Jamei K, Rabbani A (2014) How to manage idiopathic granulomatous mastitis: suggestion of an algorithm. Breast J 20(1):110–112. https://doi.org/10.1111/tbj.12216
Barreto DS, Sedgwick EL, Nagi CS et al (2018) Granulomatous mastitis: etiology, imaging, pathology, treatment, and clinical findings. Breast Cancer Res Treat 171(3):527–534. https://doi.org/10.1007/s10549-018-4870-3
Benson JR, Dumitru D (2016) Idiopathic granulomatous mastitis: presentation, investigation and management. Future Oncol 12(11):1381–1394. https://doi.org/10.2217/fon-2015-0038
Saydam M, Yilmaz KB, Sahin M, Yanik H, Akinci M, Yilmaz I, Balas S, Azili C, Gulcelik MA (2020) New findings on autoimmune etiology of idiopathic granulomatous mastitis: serum IL-17, IL-22 and IL-23 levels of patients. J Invest Surg 11:1–5. https://doi.org/10.1080/08941939.2020.1725190
Altintoprak F, Kivilcim T, Yalkin O, Uzunoglu Y, Kahyaoglu Z, Dilek ON (2015) Topical steroids are effective in the treatment of idiopathic granulomatous mastitis. World J Surg 39(11):2718–2723. https://doi.org/10.1007/s00268-015-3147-9
Azizi A, Prasath V, Canner J, Gharib M, Sadat Fattahi A, Naser Forghani M, Sajjadi S, Farhadi E, Vasigh M, Kaviani A, Omranipour R, Habibi M (2020) Idiopathic granulomatous mastitis: management and predictors of recurrence in 474 patients. Breast J 26(7):1358–1362. https://doi.org/10.1111/tbj.13822
Postolova A, Troxell ML, Wapnir IL, Genovese MC (2020) Methotrexate in the treatment of idiopathic granulomatous mastitis. J Rheumatol 47(6):924–927. https://doi.org/10.3899/jrheum.181205
Zhang X, Li Y, Zhou Y, Liu D, Chen L, Niu K, Sun Q, Huang H (2020) A systematic surgical approach for the treatment of idiopathic granulomatous mastitis: a case series. Gland Surg 9(2):261–270. https://doi.org/10.21037/gs.2020.02.06
Cetinkaya G, Kozan R, Emral AC, Tezel E (2020) Granulomatous mastitis, watch and wait is a good option. Ir J Med Sci. https://doi.org/10.1007/s11845-020-02406-0
Dag A, Edizsoy A (2021) Challenges in management of idiopathic granulomatous mastitis during the pandemic of COVID-19. Breast J 27(1):87–88. https://doi.org/10.1111/tbj.14092
Cetin K, Sıkar HE, Goret NE, Rona G, Barısık NO, Kucuk HF, Gulluoglu BM (2019) Comparison of topical, systemic, and combined therapy with steroids on idiopathic granulomatous mastitis: a prospective randomized study. World J Surg 43(11):2865–2873
Altintoprak F (2011) Topical steroids to treat granulomatous mastitis: a case report. Korean J Intern Med 26(3):356–359. https://doi.org/10.3904/kjim.2011.26.3.356
Gurleyik G, Aktekin A, Aker F et al (2012) Medical and surgical treatment of idiopathic granulomatous lobular mastitis: a benign inflammatory disease mimicking invasive carcinoma. J Breast Cancer 15(1):119–123. https://doi.org/10.4048/jbc.2012.15.1.119
Chrousos GP (2001) Glucocorticoid therapy. In: Felig P, Froh- man L (eds) Endocrinology and metabolism, 4th edn. McGraw- Hill, Incorporated, New York, pp 609–612.
Raj N, Macmillan RD, Ellis IO et al (2004) Rheumatologists and breasts: immunosuppressive therapy for granulomatous mastitis. Rheumatology 43(8):1055–1056
Wolfrum A, Kümmel S, Theuerkauf I et al (2018) Granulomatous mastitis: a therapeutic and diagnostic challenge. Breast Care (Basel) 13(6):413–418. https://doi.org/10.1159/000495
Buys LM (2007) Treatment options for atopic dermatitis. Am Fam Physician 75:523–528
Munot K, Nicholson S, Birkett V (2012) Granulomatous mastitis - a novel method of treatment. Eur J Surg Oncol 38:461e462
Lai EC, Chan WC, Ma TK et al (2005) The role of conservative treatment in idiopathic granulomatous mastitis. Breast J 11(6):454–456. https://doi.org/10.1111/j.1075-122X.2005.00127.x
Montazer M, Dadashzadeh M, MoosaviToomatari SE (2020) Comparison of the outcome of low dose and high-dose corticosteroid in the treatment of idiopathic granulomatous mastitis. Asian Pac J Cancer Prev 21(4):993–996. https://doi.org/10.31557/APJCP.2020.21.4.993
Alper F, Karadeniz E, Güven F, Yılmaz Çankaya B, Özden K, Akçay MN (2020) The evaluation of the efficacy of local steroid administration in idiopathic granulomatous mastitis: the preliminary results. Breast J 26(2):309–311. https://doi.org/10.1111/tbj.13588
Chirappapha P, Thaweepworadej P, Supsamutchai C, Biadul N, Lertsithichai P (2018) Idiopathic granulomatous mastitis: a retrospective cohort study between 44 patients with different treatment modalities. Ann Med Surg 36:162–167. https://doi.org/10.1016/j.amsu.2018.11.001
Shin Y, Park S, Song Y, Son S, Choi Y (2017) Is surgical excision necessary for the treatment of granulomatous lobular mastitis? BMC Womens Health 17(1):49. https://doi.org/10.1186/s12905-017-0412-0
Acknowledgements
The authors thanked everyone who contributed from the beginning of the article up to its publication.
Author information
Authors and Affiliations
Contributions
O. T., N. T., S. E., I. C., and S. B.: contributed to the drafting of the original grant proposal and obtained funding. O. T., N. T., and S.E. did the analyses. All the authors contributed to the interpretation of the data. O. T., S. E., I. C., and S. B. drafted the manuscript. All the authors revised the manuscript and approved the final version to be published.
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Toktas, O., Toprak, N., Elasan, S. et al. Treatment of Idiopathic Granulomatous Mastitis: Local Steroid Administration vs. Systemic (Oral) Steroid. Indian J Surg 85, 350–356 (2023). https://doi.org/10.1007/s12262-022-03447-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12262-022-03447-8